ANAVEX LIFE SCIENCES CORP. Payments of Debt Issuance Costs
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2020-09-30, per its 10-K filed 2020-12-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2020-12-28
- ANAVEX LIFE SCIENCES CORP. payments of debt issuance costs for the quarter ending 2020-09-30 was -$24.51K.
- ANAVEX LIFE SCIENCES CORP. payments of debt issuance costs for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. payments of debt issuance costs for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. payments of debt issuance costs for the quarter ending 2019-03-31 was $0.00.
- ANAVEX LIFE SCIENCES CORP. payments of debt issuance costs for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ANAVEX LIFE SCIENCES CORP. payments of debt issuance costs for fiscal 2019 was $50.00K, a 50.56% decline from fiscal 2018.
- ANAVEX LIFE SCIENCES CORP. payments of debt issuance costs for fiscal 2018 was $101.13K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$24.51K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $0.00 10-K · filed 2020-12-28 | ||
| 2020-06-30 | $24.51K 10-Q · filed 2020-08-06 | |||
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-28 | $0.00 derived: sum of 2 quarters · filed 2020-12-28 | $0.00 derived: sum of 3 quarters · filed 2020-12-28 | $50.00K 10-K · filed 2020-12-28 |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-06 | $0.00 derived: sum of 2 quarters · filed 2020-08-06 | $50.00K 10-Q · filed 2020-08-06 | $101.13K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $50.00K 10-Q · filed 2020-05-07 | $101.13K derived: sum of 3 quarters · filed 2020-05-07 | $120.19K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $50.00K 10-Q · filed 2020-02-06 | $101.13K derived: sum of 2 quarters · filed 2020-02-06 | $120.19K derived: sum of 3 quarters · filed 2020-02-06 | |
| 2018-09-30 | $51.13K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $70.19K derived: sum of 2 quarters · filed 2019-12-16 | $101.13K 10-K · filed 2019-12-16 | |
| 2018-06-30 | $19.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-07 | $50.00K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $30.94K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |